Loading
Latest filing published 13 May 2026 for Egetis Therapeutics AB (publ), €71k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Karl Hård af Segerstad is a declared insider of Egetis Therapeutics AB (publ) (board member), with filings sourced from Finansinspektionen. Between 28 November 2025 and 13 May 2026, the trades on record add up to 4 filings.
Both buying and selling appear: 2 purchases worth €11k, against 2 sales worth €142k. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 1 purchase and 2 sales on the market.
Most recently, on 13 May 2026, the filings show an open-market sale worth €71k in Egetis Therapeutics AB (publ). The last purchase on record was published on 13 May 2026, which is 157 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations